Seeing is believing: eye drops for cataracts

A company in the US, Chakshu Research, claims that it has developed an eye drop that can remove cataracts and restore vision.

The company recently completed early clinical trials at several academic centers around the US, including Johns Hopkins University, Harvard University and the University of Utah. It is about to launch Phase II/III trials early next year, and is partnering with researchers at the University of Texas at Galveston.

Its product, tentatively called C-KAD, targets the 50-plus market that is projected to reach $2 billion in annual revenue and possibly more with the rapid aging of the baby boomer demographic.